Neonatal group B streptococcal disease: Incidence, presentation, and mortality

Objectives. To ascertain the incidence, and compare the clinical characteristics, laboratory parameters, and immediate mortality of neonates with early-onset (symptomatic and asymptomatic) and late-onset group B streptococcal (GBS) disease. Methods. A chart review of 81 neonates with GBS disease (either blood and/or cerebrospinal fluid culture-proven) born between 1995 and 2002 admitted to two tertiary care perinatal centers in Toronto was conducted. Clinical characteristics were compared for (1) asymptomatic early-onset, symptomatic early-onset, and late-onset GBS disease and (2) survivors and non-survivors. Results. The incidence of GBS disease was 1.13/1000 live births. One or more antepartum or intrapartum predisposing factors were recognized in 62% of cases. Early-onset was noted in 65 (80%) neonates (23 asymptomatic and 42 symptomatic). All full-term infants survived. The mortality was 6% and was confined to preterm neonates with early symptomatic disease who presented with shock and had thrombocytopenia. Conclusion. Antepartum or intrapartum known predisposing risk factors of GBS disease were lacking in one third of patients. Patients who died were preterm infants in the early symptomatic group.

[1]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[2]  E. Eichenwald,et al.  Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening , 2005, Pediatrics.

[3]  N. Verlander,et al.  Group B streptococcal disease in UK and Irish infants younger than 90 days , 2004, The Lancet.

[4]  C. Adair,et al.  Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[5]  J. Troendle,et al.  Prematurity is the major risk factor for late-onset group B streptococcus disease. , 2003, The Journal of infectious diseases.

[6]  P. Heath,et al.  Estimated early-onset group B streptococcal neonatal disease , 2003, The Lancet.

[7]  D. Petitti,et al.  The Influence of Intrapartum Antibiotics on the Clinical Spectrum of Early-Onset Group B Streptococcal Infection in Term Infants , 2000, Pediatrics.

[8]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[9]  J. Gould,et al.  Risk Factors for Early-onset Group B Streptococcal Sepsis: Estimation of Odds Ratios by Critical Literature Review , 1999, Pediatrics.

[10]  L. Moses,et al.  Early onset group B streptococcal neonatal infection in Oxford 1985-96 , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[11]  L. Ackerson,et al.  Neonatal group B streptococcal infection in a managed care population. Perinatal Group B Streptococcal Infection Study Group. , 1998, Obstetrics and gynecology.

[12]  A. Schuchat.  Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.

[13]  T. Lieu,et al.  Neonatal Group B Streptococcal Infection in a Managed Care Population , 1998, Obstetrics and gynecology.

[14]  J. Trager,et al.  Radiological case of the month. Congenital microgastria. , 1996, Archives of pediatrics & adolescent medicine.

[15]  E. Wald,et al.  Probable community acquisition of group B Streptococcus in an infant with late-onset disease: demonstration using field inversion gel electrophoresis. , 1996, Archives of pediatrics & adolescent medicine.

[16]  A. Schuchat,et al.  Prevention of perinatal group B streptococcal disease : a public health perspective , 1996 .

[17]  A. Schuchat,et al.  Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[18]  B. Burke,et al.  Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. , 1988, The Pediatric infectious disease journal.

[19]  D. Kasper,et al.  Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. , 1981, Pediatrics.

[20]  C. Hobel,et al.  Epidemiology of the group B streptococcus: maternal and nosocomial sources for infant acquisitions. , 1979, The Journal of pediatrics.

[21]  D. Kasper,et al.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. , 1976, The New England journal of medicine.

[22]  R. Zimmerman,et al.  Group B streptococcal neonatal and infant infections. , 1973, The Journal of pediatrics.

[23]  F. Barrett,et al.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. , 1973, The Journal of pediatrics.

[24]  G. Mccracken.  Group B streptococci: the new challenge in neonatal infections. , 1973, The Journal of pediatrics.

[25]  R. H. Albert,et al.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. , 2010 .

[26]  Early-onset and late-onset neonatal group B streptococcal disease--United States, 1996-2004. , 2005, MMWR. Morbidity and mortality weekly report.

[27]  A. Schuchat,et al.  Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. , 1994, Epidemiologic reviews.

[28]  K. Bremme,et al.  Neonatal septicemia due to group B streptococci — Perinatal risk factors and outcome of subsequent pregnancies , 1988, Journal of perinatal medicine.

[29]  B. Gray,et al.  Group B streptococcal carriage and disease: a 6-year prospective study. , 1987, The Journal of pediatrics.